Skip Navigation

Publication Detail

Title: Potential protective mechanisms of aryl hydrocarbon receptor (AHR) signaling in benign prostatic hyperplasia.

Authors: Mehta, Vatsal; Vezina, Chad M

Published In Differentiation, (2011 Nov-Dec)

Abstract: The aryl hydrocarbon receptor (AHR) is an evolutionarily conserved ligand activated transcription factor best known for its role in mediating toxic responses to dioxin-like environmental contaminants. However, AHR signaling has also emerged as an active participant in processes of normal development and disease progression. Here, we review the role of AHR signaling in prostate development and disease processes, with a particular emphasis on benign prostatic hyperplasia (BPH). Inappropriate AHR activation has recently been associated with a decreased risk of symptomatic BPH in humans and has been shown to impair prostate development and disrupt endocrine signaling in rodents. We highlight known physiological responses to AHR activation in prostate and other tissues and discuss potential mechanisms by which it may act in adult human prostate to protect against symptomatic BPH.

PubMed ID: 21684673 Exiting the NIEHS site

MeSH Terms: Animals; Humans; Inflammation/metabolism; Inflammation/therapy; Male; Mice; Neovascularization, Physiologic/genetics; Prostate/growth & development*; Prostate/metabolism; Prostate/pathology; Prostatic Hyperplasia/genetics; Prostatic Hyperplasia/metabolism*; Prostatic Hyperplasia/pathology*; Receptors, Androgen/metabolism; Receptors, Aryl Hydrocarbon/agonists; Receptors, Aryl Hydrocarbon/chemistry; Receptors, Aryl Hydrocarbon/genetics*; Receptors, Aryl Hydrocarbon/metabolism*; Receptors, Estrogen/metabolism; Risk Factors; Signal Transduction/genetics

Back
to Top